EMCrit FOAM Feed · Scott D. Weingart, MD FCCM

EMCrit 422 - SSC 2026 Guidelines: The good, the Bad, and the UGLY

March 29, 2026·1 hr·5 clips

Haley argues for antibiotics within an hour in sepsis, even with very low certainty evidence.

This episode of the EMCrit Podcast features host Scott Weingart interviewing Dr. Haley Prescott, co-chair and lead author of the Surviving Sepsis Campaign 2026 Guidelines. Weingart, an emergency and critical care physician, examines the guidelines from a U.S. perspective where they often translate into rigid performance metrics. The conversation centers on the philosophical and practical tensions between guideline creation and clinical implementation. A major topic is the strong recommendation for administering antibiotics within one hour for patients with probable or definite sepsis without shock, which is based on very low certainty evidence. Weingart challenges this, citing specific studies like the FROND and FANTASY trials, a retrospective cohort, and a meta-analysis by Lung et al., which he argues show no mortality benefit until the three to six-hour mark. The discussion covers the guideline's stance on an initial 30 mL/kg fluid bolus, a point Weingart contests by referencing trials like PROCESS and PROMISE that used lower volumes. Dr. Prescott explains the committee's view that this volume is generally safe for most patients and notes the recommendation is conditional, allowing for personalized adjustment. Weingart expresses concern that such strong recommendations based on weak evidence directly feed into problematic CMS performance measures, a unique U.S. issue the international panel must still consider. An interesting insight is Dr. Prescott's description of Michigan's more nuanced registry, which uses different time targets for antibiotic administration based on patient presentation. Weingart highlights the cognitive error of conflating correlation with causation in observational studies linking treatment delays to mortality. The episode reveals a tension between writing aspirational international guidelines and their potential for rigid, local enforcement. The tone is a rigorous, collegial debate between two experts with differing operational viewpoints. Dr. Prescott is portrayed as open-minded and pragmatic, in contrast to prior committee chairs. This episode is ideal for emergency physicians, intensivists, and clinicians frustrated by the translation of sepsis guidelines into performance metrics. Listeners seeking a basic clinical overview of the guidelines might find the detailed debate on evidence grading and policy implications less relevant.

As heard by us

A clear discussion of sepsis guidelines, evidence, and how clinical advice becomes institutional force.

This episode places the Surviving Sepsis Campaign 2026 Guidelines inside the larger chain from guideline writing to quality measures, performance metrics, and pay-for-performance pressure.

Read the full review in PlayNext →

Why you'd press play

You want a hard-nosed take on how Surviving Sepsis Campaign guidance turns into bedside reality.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from EMCrit FOAM Feed